Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
Milan Lukáš Orcid.org 1
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users